fbpx

Covid-19 Antibody Drug Cocktail From Eli Lilly Cleared for Use

Covid-19 Antibody Drug Cocktail From Eli Lilly Cleared for Use

A combination of two Eli Lilly & Co. antibody-based drugs to treat recently diagnosed Covid-19 was authorized by federal health regulators, the la

Romney, Collins to Oppose Biden’s Pick to Lead Budget Office
Eighteen days after giving birth, Detroit mother dies of Covid-19
Michael Jackson estate wins appeal in lawsuit over HBO’s ‘Leaving Neverland’

A combination of two Eli Lilly & Co. antibody-based drugs to treat recently diagnosed Covid-19 was authorized by federal health regulators, the latest treatment aimed to help people at high risk of severe disease from avoiding hospitalization.

The move by the U.S. Food and Drug Administration on Tuesday night allows doctors to add a new monoclonal antibody, named etesevimab, to one called bamlanivimab that the agency authorized last year.

The combination, administered together via a single intravenous infusion, is cleared for patients who are at high risk of worsening to severe Covid-19 including those 65 and older or who have certain medical conditions.

Monoclonal antibodies are engineered proteins that mimic the immune system’s ability to fight off viruses. Regeneron Pharmaceuticals Inc. makes a similar antibody-based Covid-19 treatment that previously received FDA authorization.

Companies are developing Covid-19 antibody treatments that are more convenient to take and can tackle emerging virus mutations.

This post first appeared on wsj.com

Do You Enjoy This Article?
Sign up for our newsletter and receive FREE access to download SuccessDigest Digital Weekly Edition for attainment of your financial freedom in the new digital economy!

Invalid email address
We promise not to spam you. You can unsubscribe at any time.

COMMENTS

WORDPRESS: 0
DISQUS:
%d bloggers like this: